{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:15:20Z","timestamp":1792746920170,"version":"4.5.0"},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp; Research"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the safety and immunogenicity of live attenuated yellow fever (YF) 17D vaccine in adults receiving systemic corticosteroid therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All adult travelers on systemic corticosteroid therapy who had received the YF17D vaccine in 24 French vaccination centers were prospectively enrolled and matched with healthy controls (1:2) on age and history of YF17D immunization. Safety was assessed in a self\u2010administered standardized questionnaire within 10 days after immunization. YF\u2010specific neutralizing antibody titers were measured 6 months after vaccination in patients receiving corticosteroids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between July 2008 and February 2011, 102 vaccine recipients completed the safety study (34 receiving corticosteroids and 68 controls). The median age was 54.9 years (interquartile range [IQR] 45.1\u201360.3 years) and 45 participants had a history of previous YF17D immunization. The median time receiving corticosteroid therapy was 10 months (IQR 1\u201367 months) and the prednisone or equivalent dosage was 7 mg\/day (IQR 5\u201320). Main indications were autoimmune diseases (n = 14), rheumatoid arthritis (n = 9), and upper respiratory tract infections (n = 8). No serious adverse event was reported; however, patients receiving corticosteroids reported more frequent moderate\/severe local reactions than controls (12% and 2%, respectively; relative risk 8.0, 95% confidence interval 1.4\u201345.9). All subjects receiving corticosteroids who were tested (n = 20) had neutralizing antibody titers &gt;10 after vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>After YF17D immunization, moderate\/severe local reactions may be more frequent in patients receiving systemic corticosteroid therapy. Immunogenicity seems satisfactory. Large\u2010scale studies are needed to confirm these results.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr.22021","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T13:49:11Z","timestamp":1364824151000},"page":"1522-1528","source":"Crossref","is-referenced-by-count":35,"title":["Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study"],"prefix":"10.1002","volume":"65","author":[{"given":"Solen","family":"Kern\u00e9is","sequence":"first","affiliation":[{"name":"Paris Descartes University, INSERM, CIC BT505, and AP\u2010HP, Cochin Hospital, CICBT505 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[{"name":"Paris Descartes University, INSERM, CIC BT505, and AP\u2010HP, Cochin Hospital, CICBT505 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Ancelle","sequence":"additional","affiliation":[{"name":"Paris Descartes University and AP\u2010HP, Cochin Hospital Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Iordache","sequence":"additional","affiliation":[{"name":"INSERM, CICBT505, and AP\u2010HP, Cochin Hospital, CICBT505 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Naneix\u2010Laroche","sequence":"additional","affiliation":[{"name":"Purpan Hospital Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"M\u00e9cha\u00ef","sequence":"additional","affiliation":[{"name":"AP\u2010HP, Avicenne Hospital Bobigny France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fehr","sequence":"additional","affiliation":[{"name":"Air France Vaccination Center Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Philippe","family":"Leroy","sequence":"additional","affiliation":[{"name":"Charles Nicolle University Hospital Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Issartel","sequence":"additional","affiliation":[{"name":"Tonkin Vaccination Center Villeurbanne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dunand","sequence":"additional","affiliation":[{"name":"AP\u2010HP, Ambroise Par\u00e9 Hospital Boulogne Billancourt France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"van der Vliet","sequence":"additional","affiliation":[{"name":"INSERM, CICBT505, and AP\u2010HP, Cochin Hospital, CICBT505 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wyplosz","sequence":"additional","affiliation":[{"name":"AP\u2010HP, Bic\u00eatre Hospital Le Kremlin\u2010Bic\u00eatre France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul\u2010Henri","family":"Consigny","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Centre M\u00e9dical, Centre d'Infectiologie Necker Pasteur Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hanslik","sequence":"additional","affiliation":[{"name":"AP\u2010HP, Ambroise Par\u00e9 Hospital, Boulogne Billancourt, and Versailles Saint\u2010Quentin\u2010en\u2010Yvelines University Versailles France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,26]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples JE","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.1045"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.533"},{"key":"e_1_2_7_5_1","unstructured":"Vaccinations in the immunocompromised person: guidelines for the patient taking immunosuppressant steroids and the new biologic therapies. London: The British Society for Rheumatology;2002."},{"key":"e_1_2_7_6_1","first-page":"161","article-title":"Le calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut Conseil de la sant\u00e9 publique","volume":"14","year":"2012","journal-title":"Bull Epidemiol Hebd"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318249de59"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/597006"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2012.04.002"},{"key":"e_1_2_7_10_1","unstructured":"US Department of Health and Human Services Food and Drug Administration. Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials.2007. URL:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceCompliance RegulatoryInformation\/Guidances\/Vaccines\/ucm091977.pdf."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1999.00496.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529046"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-89102005000300012"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.009"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200403260-00020"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1086\/314031"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2007.0059"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/157016210793499277"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00686.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822009000100006"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20045"},{"key":"e_1_2_7_22_1","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul K","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.1.1"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20465"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.055657"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir660"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890470425"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60567-4"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.105"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009303"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.22021","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.22021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:08:29Z","timestamp":1759424909000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.22021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,26]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1002\/acr.22021"],"URL":"https:\/\/doi.org\/10.1002\/acr.22021","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,26]]}}}